Skip to main content

Sound Advice: July 1, 2020


Most Stocks Are Not Doing As Well As The Averages
It’s been a fascinating six months for the equity markets, especially considering how things changed when the market hit bottom on March 23rd.  Until that date, stocks such as Alphabet (a.k.a., Google) and Facebook were going nowhere fast.  Then the pandemic forced us to give up lives of flexibility and personal contact and shift to virtual life in the digital world.  Amazon, Facebook, and Netflix rose on a tidal wave of use.
It seems likely these beneficiaries will continue to prosper until the options we used to have are available again.  Their success, however, is not widely shared.
This is well illustrated by the comparison between the performance of the Standard & Poor’s 500 Index, which is capitalization-weighted, and the S&P 500 Index when measured on an equal-weighted basis.
Let me explain the difference.  The index as stated includes companies of all sizes.  Some are huge; others are tiny.  When the shares of the biggest companies rise or fall, the impact on the index could be 100 times or more than the price movement of the smallest companies.
Think of a circus with 500 animals, including elephants and monkeys.  Which do you think would carry the most weight?  It’s the same with the S&P 500 Index.
When the index is viewed on an equal-weighted basis, the impact of each of the companies is identical, regardless of size.
The comparison between the cap-weighted and equal-weight indexes is striking.
Over the last six months (essentially year to date), the cap-weighted S&P 500 index fell by 6%.  The equal-weighted index dropped by 15%.  In other words, most stocks are way behind the market.  
What are often referred as blue chips have done even worse.  Banks such as J.P. Morgan, Bank of America, and Citi are all down by more than 30%.  And then there’s AT&T, which lost 26%.
The quarters ahead will certainly be filled with further market volatility, sparked by interim reports of employment, unemployment claims, corporate earnings, actions by the Federal Reserve, campaigns for the upcoming presidential election, as well as progress in the battle against the COVID virus.  More likely than not, prices will bounce around through a broad, extended trading range while we wait for good news about therapeutics and vaccines.
Although we continue to deal with a bombardment of doom and gloom, the passing of each day gets us closer to the medical breakthroughs needed.

N. Russell Wayne, CFP®

Comments

Popular posts from this blog

Sound Advice: January 3, 2025

2025 Market Forecasts: Stupidity Taken To An Extreme   If you know anything about stock market performance, you can only gag at the nonsense “esteemed forecasters” are now putting forth about the prospective path of stocks in the year ahead.   Our cousins in the UK would call this rubbish.   I would not be as kind. Leading the Ship of Fools is the forecast from the Chief Investment Strategist at Oppenheimer who is looking for a year-end 2025 level for the Standard & Poor’s Index of 7,100, a whopping 21% increase from the most recent standing.   Indeed, most of these folks are looking for double-digit gains.   Only two expect stocks to weaken. In the last 30 years, the market has risen by more than 20% only 15 times.   The exceptional span during that time was 1996-1999, which accounted for four of those jumps.   What followed in 2000 through 2002 was the polar opposite: 2000:      -9.1% 2001:     -11.9% ...

Sound Advice: January 15, 2025

Why investors shouldn't pay attention to Wall Street forecasts   Investors shouldn't pay attention to Wall Street forecasts for several compelling reasons: Poor accuracy Wall Street forecasts have a terrible track record of accuracy. Studies show that their predictions are often no better than random chance, with accuracy rates as low as 47%   Some prominent analysts even perform worse, with accuracy ratings as low as 35% Consistent overestimation Analysts consistently overestimate earnings growth, predicting 10-12%                 annual growth when the reality is closer to 6%.   This overoptimism can                 lead investors to make overly aggressive bets in the market. Inability to predict unpredictable events The stock market is influenced by numerous unpredictable factors, including geopolitical events, technological changes, and company-specific news.   Anal...

Sound Advice: July 16, 2025

Fixed annuities are poor investments Fixed annuities are often criticized as poor investments for several reasons, despite their reputation for providing stable, predictable income.  Here are the key drawbacks and concerns:   High Fees and Commissions Internal Fees:  Fixed annuities can carry a range of fees, including administrative charges, mortality expense risk fees, and rider fees. These can add up to 2%–4% per year, significantly eroding returns over time. Commissions:  Sales agents and financial advisors often receive high commissions for selling annuities—sometimes as much as 5%–8% of the invested amount. This creates a financial incentive for advisers to recommend them, even when they may not be the best fit for the client. Comparison to Other Investments:  Mutual funds and ETFs typically have much lower fees and commissions, making them more cost-effective for long-term growth. Limited Growth a...